- 2021
Share sale
IPO NASDAQ
IPO NASDAQ
- 2019
Milestone
Share sale
- 2018
IPO NASDAQ
IPO NASDAQ
- 2017
Share sale
- 2012
NASDAQ. Acquired by Amgen
USD$1.1b
Acquired by Celgene
USD$350m + USD$575m milestones
Acquired by Jazz
Pharmaceuticals
USD$700m
- 2009
Merged with Microscience
- 2007
IPO
Oslo Børs
Advent Life Sciences. Innovation. Clarity. Execution.